ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 109

Does Joint Sonography Really Add Clinically Important Information Beyond Clinical Joint Examination?

Miriam Gärtner1, Helga Radner2, Gabriela Supp2, Peter Mandl3, Daniel Aletaha1, Klaus P. Machold4 and Josef S. Smolen5, 1Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 2Department of Internal Medicine III; Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 3Rheumatology, Medical University of Vienna, Vienna, Austria, 4Internal Medicine III, Medical University of Vienna, Vienna, Austria, 5Division of Rheumatology, Department of Internal Medicine III,, Medical University of Vienna and Hietzing Hospital, Vienna, Austria

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: remission, rheumatoid arthritis (RA) and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases: Ultrasound, Nuclear Medicine and Fluorescence Imaging

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Sonographic assessment of joint activity in patients with rheumatoid arthritis (RA) is considered to be more sensitive than the respective clinical assessment. However, this difference may be less dependent on the physical technique used (i.e. palpation vs. ultrasound), but rather related to differences in arbitrary definitions of the presence or absence of “joint activity“.  We aimed to evaluate the differences in numbers of clinically and sonographically active joints in RA, with special regard to the impact of sonographic definitions of activity.

Methods:

We performed sonographic imaging of 22 joints of the hands of RA patients in clinical remission (n=60; defined as Clinical Disease Activity Index=CDAI ≤ 2.8). Each joint was assessed for grey scale synovial hypertrophy (GSSH) and power Doppler (PD) signal on a four point scale (0=no, 1=mild, 2=moderate and 3=marked). We investigated the sensitivity and specificity of clinically swollen joints for presence of sonographic activity, when using different cut points and combinations of sonographic definitions of activity. For the clinical assessment we used the strict conventional approach of not calling a joint swollen in case of any doubt. We then assessed changes of CDAI if the clinical swollen joint count (SJC) was replaced by sonographically active joints.

Results:

Among the 1320 joints of patients in remission a total of 887 (67.2%) were GSSH positive and 269 (20.4%) were PD positive.

Clinical joint swelling was 100% specific for sonographic activity, even when stringent sonographic criteria (score=3) were applied. The maximum sensitivity was 25% using the most stringent sonographic criteria (GSSH=3 and PD=3).

Calculating CDAI by replacing the number of clinically swollen by the number of sonographically active joints (sCDAI) according to the various definitions above, resulted in high values using GSSH≥1 or PD≥1 (mean sCDAI=15.5) compared to the clinical CDAI of 1.4. However, sCDAI values approached the clinical CDAI with increasing stringency of the sonographic definition used, and were even numerically identical when accepting only grade 3  PD signals (Figure).

Conclusion:

Sonography revealed residual signals of joint activity in patients in CDAI remission. Changing the stringency of the sonographic criteria toward higher signals for determination of joint activity led to similar results when considered in the context of overall disease activity, such as in the CDAI.


Disclosure:

M. Gärtner,
None;

H. Radner,
None;

G. Supp,
None;

P. Mandl,
None;

D. Aletaha,
None;

K. P. Machold,
None;

J. S. Smolen,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/does-joint-sonography-really-add-clinically-important-information-beyond-clinical-joint-examination/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology